Nephros, Inc. (NEPH) financial statements and ratios from SEC XBRL: revenue $18.79M (TTM), net margin 6.4%, revenue growth 32.7% YoY, P/E 37.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $18.79M |
| Net Margin | 6.4% |
| Revenue Growth (YoY) | 32.7% |
| EPS Growth (YoY) | 1000.0% |
| P/E Ratio | 37.6 |
| EV / EBITDA | 33.1 |
| Price / Book | 4.47 |
| Price / Sales | 2.48 |
| DCF Value (model) | $2.50 |
| DCF Upside vs Price | -43.2% |
| Altman Z-Score | -4.11 (distress) |
| Sector P/E (Healthcare) | 21.6 |
NEPH overview · NEPH earnings · NEPH KPIs · NEPH investor relations · NEPH ownership · NEPH peers · NEPH filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.